Literature DB >> 12939262

Distinct transcriptional activation functions of STAT1alpha and STAT1beta on DNA and chromatin templates.

Natalia Zakharova1, Elena S Lymar, Edward Yang, Sohail Malik, J Jillian Zhang, Robert G Roeder, James E Darnell.   

Abstract

Interferon-induced transcription depends upon tyrosine phosphorylation, subsequent dimerization, and binding to DNA of STAT1. Other factors, including but not necessarily limited to CBP/p300, then bind within the C-terminal 38 amino acid transactivation domain (TAD) to activate transcription. We show that both tyrosine-phosphorylated STAT1alpha (full-length wild-type protein) and STAT1beta (lacking the TAD) stimulate in vitro transcription on a naked DNA template. Furthermore, in a system with purified proteins and naked DNA, STAT1alpha- and STAT1beta-dependent transcription is stimulated by the TRAP/Mediator co-activator complex. Thus STAT1, through some site other than the C-terminal TAD, can interact with TRAP/Mediator or some intermediate protein. Although both STAT1alpha and STAT1beta bind to known STAT sites within in vitro assembled chromatin templates, only STAT1alpha, and not STAT1beta, in cooperation with p300 and acetyl-CoA, stimulated in vitro transcription from chromatin. After interferon-gamma treatment, cells recruit STAT1alpha or -beta to the chromosomal interferon-1 gene, but only STAT1alpha-containing cells recruit p300 and stimulate transcription. We conclude that chromatin remodeling by p300 in vivo makes TRAP/Mediator effective in stimulating transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939262     DOI: 10.1074/jbc.M308166200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

Authors:  Katrin Friedbichler; Marc A Kerenyi; Boris Kovacic; Geqiang Li; Andrea Hoelbl; Saliha Yahiaoui; Veronika Sexl; Ernst W Müllner; Sabine Fajmann; Sabine Cerny-Reiterer; Peter Valent; Hartmut Beug; Fabrice Gouilleux; Kevin D Bunting; Richard Moriggl
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

2.  Mutations in the linker domain affect phospho-STAT3 function and suggest targets for interrupting STAT3 activity.

Authors:  Claudia Mertens; Bhagwattie Haripal; Sebastian Klinge; James E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

3.  Signal transducer and activator of transcription 1 negatively regulates constitutive gamma interferon-inducible lysosomal thiol reductase expression.

Authors:  Priya Srinivasan; Maja Maric
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 4.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

Review 5.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

6.  The role of stat1b in zebrafish hematopoiesis.

Authors:  Hao Song; Yi-lin Yan; Tom Titus; Xinjun He; John H Postlethwait
Journal:  Mech Dev       Date:  2011-09-03       Impact factor: 1.882

7.  STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity.

Authors:  Christian Semper; Nicole R Leitner; Caroline Lassnig; Matthias Parrini; Tanel Mahlakõiv; Michael Rammerstorfer; Karin Lorenz; Doris Rigler; Simone Müller; Thomas Kolbe; Claus Vogl; Thomas Rülicke; Peter Staeheli; Thomas Decker; Mathias Müller; Birgit Strobl
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

8.  Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.

Authors:  Jonathan M Wojciak; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

9.  Multiple kinases in the interferon-gamma response.

Authors:  D Watling; C R Carmo; I M Kerr; A P Costa-Pereira
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-15       Impact factor: 11.205

10.  A partial form of recessive STAT1 deficiency in humans.

Authors:  Ariane Chapgier; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Emmanuelle Jouanguy; Diana Averbuch; Jacqueline Feinberg; Shen-Ying Zhang; Jacinta Bustamante; Guillaume Vogt; Julien Lejeune; Eleonore Mayola; Ludovic de Beaucoudrey; Laurent Abel; Dan Engelhard; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.